Research, Select, & Monitor Friday, March 22, 2019 6:23:22 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Amicus Therapeutics Inc.$13.26($.56)(4.05%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Amicus Therapeutics Inc. vs Chemicals - Major Diversified

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $91.3 Mil $80,772.8 Mil
  Market Cap: $2,616.0 Mil $178,177.9 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: 147.1% 16.8%
  Estimated Revenue: N/A 1.6%
  Historic Earnings: N/A 25.0%
  Estimated Earnings: N/A 12.8%
  Stock Price (1 Year): (7.1%) (13.7%)
  Cash per Share: 42.8% (16.2%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 15.6
  Price-to-Sales: 28.7 N/A
  Price-to-Book: 7.6 3.2
  Dividend Yield: N/A N/A
  Market Cap: $2,616.0 Mil $22,272.2 Mil
  Net Margin: (382.5%) 11.9%
  Gross Margin: 84.2% 29.3%
  Return on Equity: (1.0) .2
  Return on Assets: (.4) .1
  Balance Sheet
  Current Ratio: 6.4 1.9
  Quick Ratio: 6.3 1.3
  Cash Ratio: 5.9 .4
  Debt-to-Equity: 1.3 1.9
  Interest Coverage: .1 .8
  Relative-Strength Index: 63.6 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $25.71 $55,076.5 Mil
  Air Products & Chemicals, Inc.  (APD) $187.19 $41,369.0 Mil
  Henkel KGaA  (HENKY) $23.40 $24,311.6 Mil
  Akzo Nobel N.V.  (AKZOY) $30.82 $21,046.1 Mil
  Celanese Corp  (CE) $102.68 $13,153.3 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.